The effect of propofol on midazolam metabolism in human liver microsome suspension

Anaesthesia

Volumn 52, Issue 10, 1997, Pages 945-948

  Leung, B P ^a   Miller, E ^a   Park, G R ^a  

^a John Farman Intensive Care Unit   (United Kingdom)

Author keywords

Anaesthetics; Benzodiazepines; Intravenous; Liver microsomes; Midazolam. metabolism; Propofol. hypnotics

Indexed keywords

BENZODIAZEPINE DERIVATIVE; INTRAVENOUS ANESTHETIC AGENT; LIPID; MIDAZOLAM; PROPOFOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LIVER MICROSOME; METHODOLOGY;

EID: 0030721444     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.225-az0360.x     Document Type: Article

References (14)

1. Park GR, Godsiff L, Magee L. Cosedation in the critically ill. Anaesthesia 1995; 50: 1004-5.
2. Garforth R, Keilani MRZ, Park GR. Combinations of drugs for induction and maintenance anaesthesia and sedation of the critically ill. Middle East Journal of Anesthesiology 1996; 13: 545-57.
3. Janicki PK, James MF, Erskine WA. Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. British Journal of Anaesthesia 1992; 68: 311-2.
4. Baker MT, Chadam MV, Ronnenberg WC. Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes. Anesthesia and Analgesia 1993; 76: 817-21.
5. Chen TL, Ueng TH, Chen SH, Lee PH, Fan SZ, Liu CC. Human cytochrome P450 mono-oxygenase system is suppressed by propofol. British Journal of Anaesthesia 1995; 74: 558-62.
6. Yun Y, Casazza JP, Sohn DH, Veech RL, Song BJ. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Molecular Pharmacology 1992; 41: 474-9.
7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265-75.
8. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370-8.
9. Park GR, Miller E, Navapurkar V. What changes drug metabolism II. Serum from critically ill patients inhibits cytochrome P450 3A. Anaesthesia 1966; 51: 11-5.
10. Vuyk J, Engbers FHM, Lemmens HJM. Pharmacokinetics of propofol in female patients. Anesthesiology 1992; 77: 3-9.
11. Kantos J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clinical Pharmacology 1989; 17: 308-26.
12. 14C propofol. Xenobiotica 1991; 21: 1325-35.
13. Jenstrup M, Freuergaard K, Neilsen J, Moeller AM, Wiberg-Joergensen F. Alfentanil infusion in total intravenous anaesthesia (TIVA). Population pharmacokinetics fails to predict plasma concentration of alfentanil. Acta Anaesthesiologica Scandinavica 1992; 36: 846-7.
14. Gepts E, Jonckheer K, Maes V, Camu F. Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia 1988; 43: S8-S13.